















































r14th International Congress on Infectious Diseases (ICID) Abs
pital based series could be used as an alternative source to
estimate the global burden of IE.
doi:10.1016/j.ijid.2010.02.1613
25.012
The impact of a microbial sealant to reduce surgical site
infection reduction in cardiac surgery
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Background: Surgical site infection (SSI) do have a serious
impact on patients undergoing cardiac surgery. This study
was performed to prove if additional preoperative care by
using a microbial sealant can reduce surgical site infection.
Methods: To improve preoperative surgical care two
groups of patients were identiﬁed during thes same period
of time. Between January and August 2007, a control
group (n = 718), receiving standard institutional preopera-
tive preparation and between January and August 2008,the
InteguSeal group (n = 780) who received additionally amicro-
bial sealant prior to sternotomy. Both groups were evaluated
by patients characteristics and a pre-operative risk scores.
End-point of this study was freedom from SSI.
Results: Follow up was 100% completed. The values of
the pre-operative risk score of the control group and the
InteguSeal group was signiﬁcantly different in both groups,
respectively 9.7.± 1.5 and 10.1± 1.8 (p = 0.001).
The clinical end-point, however showed a highly signif-
icant decrease of SSI in the InteguSeal group 1.4% (n = 11)
compared with the control group 4.3% (n = 31), (p < 0.003)
althrough they were at higher risk for SSI.
Conclusion: Thus, the pre-operative risk score for
patients of the InteguSeal group was signiﬁcant higher com-
pared to the control group, there was a highly signiﬁcant
reduction of surgical site infections seen.
doi:10.1016/j.ijid.2010.02.1614
25.013
The global burden of infective endocarditis: Methodol-
ogy for a systematic review to assess disease burden and
trends in 21 world regions for 1990-2005
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Background: Infective endocarditis(IE) is an important
contributor to mortality and morbidity worldwide. However,




isk factors(GBD) has not included speciﬁc assessment of
he burden of IE and its sequelea. We aimed to describe
he methdology for a comprehensive assessment of IE bur-
en trends in 21 world regions for 1990-2005 as part of the
urrent GBD 2005 effort.
Methods: A systematic review of published studies, sur-
eys,and other data sources is being conducted in order
o assess the global epidemiology of IE and related dis-
bling sequelae. Cases of IE were deﬁned according to the
uke, modiﬁed Duke, Steckelberg,Von Reyn and modiﬁed
on Reyn. A simpliﬁed model was used for the system-
tic review and it included cure,valve surgery,stroke, and
eath.Electronic databases included.
MEDLINE,EMBASE,LILACK, KoreaMED, AMED, EXTRAMED,
copus and web of science.Only population based studies
ere used to estimte the incidence.
Results: We identiﬁed 121 studies: 21 population-
ased,21 multicenter studies, and 79 hospital cohorts.
ata originated from 40 countries and 2 international
ollaborations. Only 18 population based studies reported
n the incidence of IE/100,000 in 9 countries.Australia(3),
rance (2.2,3), Denmark(2.4,2.7),Italy (3.6), Nether-
ands(1.5,9.6), Sweden(0.39,6.2), Tunisia(5.5), UK(1.6,2.3),
SA(1.7,3.8,4.2,4.95,11.6). Valve replacement was per-
ormed on 30%(mean) and 29%(median) of IE cases.Stroke
ccured in 15%(mean)and 14%(median).Mortality occured
n 23%(mean) and 21%(median) of cases. Bias secondary
o incomplete data, non representative populations, and
issing data for national or regional populations remain
mportant challenge. Speciﬁc strategies to address this lim-
tation are ongoing and include (1) translating non-English
tudies (2) searching the gray literature; and (3) contacting
E experts in world regions with limited or no data.
Conclusion: A comprehensive and systematic assessment
f the global burden and trends in IE mortality and disability
sing a rigorous methodology is being conducted. IE is a rel-
tively uncommon disease but is associated with signiﬁcant
orbidity and mortality. Completion of this effort will add




soas abscess in Korea: Etiology, clinical features, treat-
ent and outcome
.W. Kang ∗, Y.J. Kim, K.-W. Hong, S.I. Kim, Y.R. Kim
The catholic University of Korea, Seoul, Korea, Republic of
Background: Abscess of the psoas muscle is a rare dis-
ase. Because of nonspeciﬁc presentation, it is difﬁcult to
iagnosis. There is a wide spectrum in etiology, time to diag-
osis, and therapeutic options. This study is to describe the
tiology, clinical features, treatment, and outcome of psoas
bscess from multicenter in Korea.
Methods: We retrospectively reviewed the medical
ecords of patients with psoas muscle abscess who were
dmitted to three university hospitals in Korea over 10 years.
Results: A total of 87 patients (46 male, 41 female) were
ncluded in this study. The mean age was 56.3± 18.5 years
ld. The mean duration of hospitalization was 31.9± 24.37
